New mRNA vaccine aims to stop ovarian Cancer's return
Disease control
Recruiting now
This early-stage trial tests a new mRNA cancer vaccine called CryptiVax-1001 in 50 women with advanced ovarian cancer. The vaccine is designed to train the immune system to recognize and attack cancer cells, potentially delaying or preventing the cancer from coming back. The main…
Phase: PHASE1 • Sponsor: Epitopea Ltd • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC